Andreas Tiede/ResearchGate
Dec 21, 2025, 23:09
Andreas Tiede: The Most Important Things for Hemophilia Practice
Andreas Tiede, Professor, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation at Hannover Medical School, shared a post on LinkedIn:
“ASH2025: The most important things for hemophilia practice. Link below
The congress is over – but which data is really relevant for our everyday hospital life? Together with a great team of experts, I filter the highlights for you.
Join our virtual event “Talking Haemofuture” and get a compact update on:
- Hemophilia Pediatrics: Clinical + Real-World Data
- Future: New Approaches in Gene Therapy and Basic Research
- Practice: Joint Health and Risk Management
- Innovation: New treatment options in hemophilia
Also present: Dr. Sebastian Hütker, Prof. Dr. Cihan Ay, Dr. Christiane Dobbelstein, and Prof. Dr. Alexandra Russo.
14 January 2026 | 5:00 p.m. – 7:00 p.m.
Registration and Stream:
I look forward to the exchange!”
Find more posts featuring Andreas Tiede on Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy